Luca A. Vitali

Dr. Luca A. Vitali

University of Camerino - School of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Food Research International
Verified
Journal Article
Closed access
ANAstride Franks Kamgang Nzekoue
Astride Franks Kamgang Nzekoue
Simone AngeloniSimone Angeloni
Simone Angeloni
LNLuciano Navarini
Luciano Navarini
CACristina Angeloni
Cristina Angeloni
MFMichela Freschi
Michela Freschi
Giovanni CaprioliGiovanni Caprioli
Giovanni Caprioli

1 November 2016 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
Luca A. VitaliLuca A. Vitali
Luca A. Vitali
DBDaniela Beghelli
Daniela Beghelli
PNProsper C. Biapa Nya
Prosper C. Biapa Nya
OBOnelia Bistoni
Onelia Bistoni
Loredana CappellacciLoredana Cappellacci
Loredana Cappellacci
MBMassimo Bramucci
Massimo Bramucci
Trachyspermum ammi (Apiaceae) is a plant with a good reputation in the traditional Persian and Ajurvedic medicine. The hydrodistilled essential oil from the fruits of T. ammi, known as ‘ajwain oil’, is used in countries like Iraq, Iran, Afghanistan, Pakistan, and India in the preparation of curry, to flavor several foods, as preservative, and in perfumery. At therapeutic level, ajwain oil is employed in the treatment of gastrointestinal ailments, lack of appetite and bronchial problems. In the present work, the essential oil of T. ammi growing in Iran was analysed by GC-FID and GC-MS showing thymol (67.4%), p-cymene (17.9%) and γ-terpinene (11.3%) as the major constituents. Afterwards, we investigated the biological effects displayed by ajwain oil, namely the antimicrobial and antioxidant activity, the cytotoxicity on tumor cells, and the induction of lymphocyte proliferation. In addition, the inhibition on nicotinate mononucleotide adenylyltransferase (NadD), which is a promising new target for developing novel antibiotics, was evaluated. The antimicrobial effects of ajwain oil, measured by the agar disc diffusion method, were relevant, with inhibition zones higher than those of reference antibiotics, especially on S. aureus and C. albicans (34.7 and 54.3 mm, respectively). This effect was not due to the enzymatic inhibition on NadD. The ajwain oil exhibited a considerable dose-dependent inhibition on the ABTS radical cation, with an IC50 value of 22.4 µg/mL. MTT assay revealed that ajwain oil is particularly cytotoxic on colon carcinoma cells, with a IC50 value of 9.6 µg/mL. Finally, PBMC proliferation assay revealed some role for the ajwain oil within the network of interactions of the cells of the immune system

1 April 2007 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
ABAndrea Brenciani
Andrea Brenciani
ABAlessandro Bacciaglia
Alessandro Bacciaglia
MVManuela Vecchi
Manuela Vecchi
Luca A. VitaliLuca A. Vitali
Luca A. Vitali
PVPietro E. Varaldo
Pietro E. Varaldo
ELEONORA GIOVANETTIELEONORA GIOVANETTI
ELEONORA GIOVANETTI
This study was directed at characterizing the genetic elements carrying the methylase gene erm (B), encoding ribosome modification-mediated resistance to macrolide, lincosamide, and streptogramin B (MLS) antibiotics, in Streptococcus pyogenes . In this species, erm (B) is responsible for MLS resistance in constitutively resistant isolates (cMLS phenotype) and in a subset (iMLS-A) of inducibly resistant isolates. A total of 125 erm (B)-positive strains were investigated, 81 iMLS-A (uniformly tetracycline susceptible) and 44 cMLS (29 tetracycline resistant and 15 tetracycline susceptible). Whereas all tetracycline-resistant isolates carried the tet (M) gene, tet (M) sequences were also detected in most tetracycline-susceptible isolates (81/81 iMLS-A and 7/15 cMLS). In 2 of the 8 tet (M)-negative cMLS isolates, erm (B) was carried by a plasmid-located Tn 917 -like transposon. erm (B)- and tet (M)-positive isolates were tested by PCR for the presence of genes int (integrase), xis (excisase), and tndX (resolvase), associated with conjugative transposons of the Tn 916 family. In mating experiments using representatives of different combinations of phenotypic and genotypic characteristics as donors, erm (B) and tet (M) were consistently cotransferred, suggesting their linkage in individual genetic elements. The linkage was confirmed by pulsed-field gel electrophoresis and hybridization studies, and different elements, variably associated with the different phenotypes/genotypes, were detected and characterized by amplification and sequencing experiments. A previously unreported genetic organization, observed in all iMLS-A and some cMLS isolates, featured an erm (B)-containing DNA insertion into the tet (M) gene of a defective Tn 5397 , a Tn 916 -related transposon. This new element was designated Tn 1116 . Genetic elements not previously described in S. pyogenes also included Tn 6002 , an unpublished transposon whose complete sequence is available in GenBank, and Tn 3872 , a composite element resulting from the insertion of the Tn 917 transposon into Tn 916 [associated with a tet (M) gene expressed in some cMLS isolates and silent in others]. The high frequency of association between a tetracycline-susceptible phenotype and tet (M) genes suggests that transposons of the Tn 916 family, so far typically associated solely with a tetracycline-resistant phenotype, may be more widespread in S. pyogenes than currently believed.

9 March 2018 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
Giovanni GherardiGiovanni Gherardi
Giovanni Gherardi
Luca A. VitaliLuca A. Vitali
Luca A. Vitali
RCRoberta Creti
Roberta Creti
Background: Streptococcus pyogenes or group A streptococcus (GAS) is an important human pathogen responsible for a broad range of infections, from uncomplicated to more severe and invasive diseases with high mortality and morbidity. Epidemiological surveillance has been crucial to detect changes in the geographical and temporal variation of the disease pattern; for this purpose the M protein gene (emm) gene typing is the most widely used genotyping method, with more than 200 emm types recognized. Molecular epidemiological data have been also used for the development of GAS M protein-based vaccines. Methods: The aim of this paper was to provide an updated scenario of the most prevalent GAS emm types responsible for invasive infections in developed countries as Europe and North America (US and Canada), from 1st January 2000 to 31st May 2017. The search, performed in PubMed by the combined use of the terms (“emm”) and (“invasive”) retrieved 264 articles, of which 38 articles (31 from Europe and 7 from North America) met the inclusion criteria and were selected for this study. Additional five papers cited in the European articles but not retrieved by the search were included. Results: emm1 represented the dominant type in both Europe and North America, replaced by other emm types in only few occasions. The seven major emm types identified (emm1, emm28, emm89, emm3, emm12, emm4, and emm6) accounted for approximately 50–70% of the total isolates; less common emm types accounted for the remaining 30–50% of the cases. Most of the common emm types are included in either one or both the 26-valent and 30-valent vaccines, though some well-represented emm types found in Europe are not. Conclusion: This study provided a picture of the prevalent emm types among invasive GAS (iGAS) in Europe and North America since the year 2000 onward. Continuous surveillance on the emm-type distribution among iGAS infections is strongly encouraged also to determine the potential coverage of the developing multivalent vaccines.

2 May 2000 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JTJerneja Tomšic
Jerneja Tomšic
Luca A. VitaliLuca A. Vitali
Luca A. Vitali
TDTina Daviter
Tina Daviter
ASAndreas Savelsbergh
Andreas Savelsbergh
RSRoberto Spurio
Roberto Spurio
CGClaudio O. Gualerzi
Claudio O. Gualerzi
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.